Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole Genome Sequencing Demonstrates Fidaxomicin is Superior to Vancomycin for Prevention of Clostridium difficile Relapse and Reinfection

ABSTRACT: Whole Genome Sequencing Demonstrates Fidaxomicin is Superior to Vancomycin for Prevention of Clostridium difficile Relapse and Reinfection

PROVIDER: PRJEB4638 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR347956_1.fastq.gz	Fastqsanger.gz
	ERR347956_2.fastq.gz	Fastqsanger.gz
	ERR347957_1.fastq.gz	Fastqsanger.gz
	ERR347957_2.fastq.gz	Fastqsanger.gz
	ERR347958_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 370

Similar Datasets

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile.

Project description: Not available

| S-EPMC3982846 | biostudies-literature

Relapse and Reinfection in Tuberculosis

Project description:Relapse and Reinfection in Tuberculosis

| PRJEB2777 | ENA

B cell characteristics define HCV reinfection outcome

Project description:In individuals highly exposed to hepatitis C virus (HCV), reinfection is common, suggesting that natural development of sterilising immunity is difficult. In those that are reinfected, some will develop a persistent infection, while a small proportion repeatedly clear the virus, suggesting natural protection is possible. The aim of this study was to characterise immune responses associated with rapid natural clearance of HCV reinfection. Broad neutralising antibodies (BnAbs) and Envelope 2 (E2)-specific memory B cell (MBCs) responses were examined longitudinally in 15 subjects with varied reinfection outcomes. BnAb responses were associated with MBC recall, but not with reinfection clearance. Strong evidence of antigen imprinting was found, and the B cell receptor repertoire showed a high level of clonality with ongoing somatic hypermutation of many clones over subsequent reinfection events. Single cell transcriptomic analyses showed that cleared reinfections featured an activated transcriptomic profile in HCV-specific B cells that rapidly expanded upon reinfection. MBC quality, but not necessarily breadth of nAb responses, is important for protection against antigenically diverse variants, which is encouraging for HCV vaccine development.

2024-06-13 | GSE269792 | GEO

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.

Project description: Not available

| S-EPMC3388025 | biostudies-literature

Autocrine GM-CSF signaling programs hematopoietic stem and progenitor cells during Candida albicans infection for protection against reinfection

Project description:More mechanistic studies are needed to reveal the hidden details of in vivo-induced trained immunity. Here, using a Candida albicans live vaccine mouse model we show that vaccination protects mice against a secondary infection and increases the number of bone marrow, and especially, splenic trained monocytes. Moreover, vaccination reprograms hematopoietic stem and progenitor cells (HSPCs) early during infection and mobilize them transiently to the spleen to produce trained macrophages. Trained HSPCs are not only primed for myeloid cell production but also reprogramed to produce a greater amount of proinflammatory cytokines in response to a second challenge; additionally, their adoptive transfer is sufficient to protect mice against reinfection. Mechanistically, autocrine GM-CSF activation of HSPCs is responsible for the trained phenotype and essential for the vaccine-induced protection. Our findings reveal a fundamental role for HSPCs in the trained immune protective response, opening new avenues for disease prevention and treatment.

2021-12-06 | GSE184104 | GEO

B cell characteristics define HCV reinfection outcome

Project description:B cell characteristics define HCV reinfection outcome

| PRJNA1123702 | ENA

Diabetes Prevention Program (DPP)

Project description:Diabetes Prevention Program (DPP)

| PRJNA227394 | ENA

Role of IFITM3 during primary influenza infection and reinfection

Project description:Role of IFITM3 during primary influenza infection and reinfection

| PRJNA762290 | ENA

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial

Project description:Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial